P. Michel, M. Lathelize, J. Quenon, R. Bru-sonnet, S. Domecq et al., Comparaison des deux Enquêtes Nationales sur les Événements Indésirables graves associés aux Soins menées en, Rapport final à la DREES (Ministère de la Santé et des Sports) ? Mars, 2004.

D. Bates, D. Cullen, N. Laird, L. Petersen, S. Small et al., Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group, JAMA: The Journal of the American Medical Association, vol.274, issue.1, pp.29-34, 1995.
DOI : 10.1001/jama.274.1.29

D. Bates, N. Spell, D. Cullen, E. Burdick, N. Laird et al., The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group, JAMA: The Journal of the American Medical Association, vol.277, issue.4, pp.307-318, 1997.
DOI : 10.1001/jama.277.4.307

S. Kane, R. Weber, and J. Dasta, The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med, pp.691-699, 2003.

B. Kopp, M. Mrsan, B. Erstad, and J. Duby, Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist, American Journal of Health-System Pharmacy, vol.64, issue.23, pp.2483-2490, 2007.
DOI : 10.2146/ajhp060674

R. Maclaren, C. Bond, S. Martin, and D. Fike, Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med, pp.3184-3193, 2008.

C. Bond and C. Raehl, Clinical Pharmacy Services, Pharmacy Staffing, and Adverse Drug Reactions in United States Hospitals, Pharmacotherapy, vol.58, issue.2, pp.735-782, 2006.
DOI : 10.1592/phco.24.5.441.33354

C. Bond and C. Raehl, Clinical Pharmacy Services, Pharmacy Staffing, and Hospital Mortality Rates, Pharmacotherapy, vol.58, issue.4, pp.481-93, 2007.
DOI : 10.2146/ajhp050291

C. Bond, C. Raehl, and T. Franke, Clinical Pharmacy Services, Pharmacy Staffing, and the Total Cost of Care in United States Hospitals, Pharmacotherapy, vol.14, issue.3, pp.609-630, 2000.
DOI : 10.1001/jama.278.6.485

G. Schumock, P. Meek, P. Ploetz, and L. Vermeulen, Economic Evaluations of Clinical Pharmacy Services: 1988-1995, Pharmacotherapy, vol.16, issue.6, pp.1188-1208, 1996.

G. Schumock, M. Butler, P. Meek, L. Vermeulen, B. Arondekar et al., Evidence of the Economic Benefit of Clinical Pharmacy Services: 1996???2000, Pharmacotherapy, vol.58, issue.4, pp.113-132, 2000.
DOI : 10.1023/A:1008748920744

A. Perez, F. Doloresco, J. Hoffman, P. Meek, D. Touchette et al., Economic Evaluations of Clinical Pharmacy Services: 2001???2005, Pharmacotherapy, vol.29, issue.1, p.128, 2009.
DOI : 10.1592/phco.29.1.128

B. Allenet, P. Arnauld, Y. Azizi, T. Baum, J. Bonhomme et al., Réaliser une conciliation des traitements médicamenteux à l'admission du patient hospitalisé

N. Instruction, . Dgos, and . Pf2, 65 du 9 mars 2015 relative à la mise en oeuvre d'une enquête nationale sur le déploiement de la conciliation médicamenteuse dans les établissements de santé - Validée par le CNP le 06 mars, pp.2015-2015, 2015.

X. Pourrat, H. Corneau, S. Floch, M. Kuzzay, L. Favard et al., Communication between community and hospital pharmacists: impact on medication reconciliation at admission, International Journal of Clinical Pharmacy, vol.43, issue.6, pp.656-63, 2013.
DOI : 10.1345/aph.1L597

T. Vira, M. Colquhoun, and E. Etchells, Reconcilable differences: correcting medication errors at hospital admission and discharge. Qual Saf Health Care, pp.122-128, 2006.

L. Smith, J. Mosley, S. Lott, E. Cyr, . Jr et al., Impact of pharmacy-led medication reconciliation on medication errors during transition in the hospital setting, Pharmacy Practice, vol.13, issue.4
DOI : 10.18549/PharmPract.2015.04.634

J. Kramer, M. Stewart, S. Fogg, B. Schminke, R. Zackula et al., A Quantitative Evaluation of Medication Histories and Reconciliation by Discipline, Hospital Pharmacy, vol.277, issue.9, pp.826-838, 2014.
DOI : 10.1001/jama.1997.03540280039031

M. Colombe, S. Blanchemain, A. Six, V. Kowalski, and P. Lescure, Impact d???un processus complet de conciliation des traitements m??dicamenteux en court s??jour g??riatrique sur le nombre d???erreurs m??dicamenteuses aux interfaces ville/h??pital, Le Pharmacien Hospitalier et Clinicien, vol.49, issue.2, pp.20-21, 2014.
DOI : 10.1016/j.phclin.2014.04.079

J. Sebaaly, L. Parsons, N. Pilch, W. Bullington, G. Hayes et al., Clinical and Financial Impact of Pharmacist Involvement in Discharge Medication Reconciliation at an Academic Medical Center: A Prospective Pilot Study, Hospital Pharmacy, vol.58, issue.1, pp.505-518
DOI : 10.1331/JAPhA.2013.11250

M. Marquis-implementation, A Guide for Medication Reconciliation Quality Improvement. Society of Hospital Medicine, 2014.

S. Doerper, J. Godet, J. Alexandra, B. Allenet, E. Andres et al., Development and multi-centre evaluation of a method for assessing the severity of potential harm of medication reconciliation errors at hospital admission in elderly, European Journal of Internal Medicine, vol.26, issue.7, pp.491-498, 2015.
DOI : 10.1016/j.ejim.2015.07.014

P. Bedouch, Analyse pharmaceutique des prescriptions médicamenteuses Journées OMEDIT Languedoc-Roussillon -12 juin 2013 -Montpellier

R. Article and . Décret, -art. 1 JORF 16 juin 2004 -Abrogé par Décret, 2004.

H. Folli, R. Poole, W. Benitz, and J. Russo, Medication error prevention by clinical pharmacists in two children's hospitals. Pediatrics, pp.718-740, 1987.

H. Hatoum, R. Hutchinson, L. Elliott, and D. Kendzierski, Physicians' Review of Significant Interventions by Clinical Pharmacists in Inpatient Care, Drug Intelligence & Clinical Pharmacy, vol.45, issue.12, pp.980-982, 1988.
DOI : 10.1177/106002808602000105

C. Bayliff and T. Einarson, Physician assessment of pharmacists' interventions : a method of estimating cost avoidance and determining quality assurance. Can J Hosp Pharm, 1990.

H. Hatoum, R. Hutchinson, K. Witte, and G. Newby, Evaluation of the Contribution of Clinical Pharmacists: Inpatient Care and Cost Reduction, Drug Intelligence & Clinical Pharmacy, vol.20, issue.3, pp.252-261, 1988.
DOI : 10.1177/106002808602000207

G. Haig and L. Kiser, Effect of pharmacist participation on a medical team on costs, charges, and length of stay, Am J Hosp Pharm, vol.48, issue.7, pp.1457-62, 1991.

V. Chedru and M. Juste, Evaluation médicale de l'impact clinique des interventions pharmaceutiques, J Pharm Clin, vol.16, issue.4, 1997.

Y. Tasaka, D. Yasunaga, M. Tanaka, A. Tanaka, T. Asakawa et al., Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan, International Journal of Clinical Pharmacy, vol.36, issue.2, pp.321-330
DOI : 10.1345/aph.1A333

S. Ibáñez-garcia, C. Rodriguez-gonzalez, M. Martin-barbero, M. Sanjurjo-saez, and A. Herranz-alonso, Adding value through pharmacy validation: a safety and cost perspective, Journal of Evaluation in Clinical Practice, vol.54, issue.3, 2016.
DOI : 10.1046/j.1365-2125.2003.02029.x

A. Guignon, F. Grain, B. Allenet, E. Brudieu, C. Barjhoux et al., Assessment of the clinical impact of pharmacists' recommendations in a medical care unit, J Pharm Clin, vol.20, issue.2, 2001.

G. Schumock, R. Hutchinson, and B. Bilek, Comparison of two systems for documenting pharmacist interventions in patient care, Am J Hosp Pharm, vol.49, issue.9, pp.2211-2215, 1992.

R. Mason, C. Pugh, S. Boyer, and K. Stiening, Computerized documentation of pharmacists' interventions, Am J Hosp Pharm, vol.51, issue.17, pp.2131-2139, 1994.

J. Calop, Pharmacie clinique et thérapeutique -4ème édition, p.1336, 2012.

A. Drenth-van-maanen, R. Van-marum, W. Knol, C. Van-der-linden, and P. Jansen, Prescribing Optimization Method for Improving Prescribing in Elderly Patients Receiving Polypharmacy, Drugs & Aging, vol.57, issue.2, pp.687-701, 2009.
DOI : 10.1093/qjmed/hch051

Y. Juillet, Le m??dicament, Annales Pharmaceutiques Fran??aises, vol.63, issue.2, pp.119-143, 2005.
DOI : 10.1016/S0003-4509(05)82261-8

E. Topinková, J. Baeyens, J. Michel, and P. Lang, Evidence-based strategies for the optimization of pharmacotherapy in older people. Drugs Aging, pp.477-94, 2012.

L. Magedanz, E. Silliprandi, D. Santos, and R. , Impact of the pharmacist on a multidisciplinary team in an antimicrobial stewardship program: a quasi-experimental study, International Journal of Clinical Pharmacy, vol.33, issue.Suppl 2, 2012.
DOI : 10.1086/321880

S. Bevilacqua, B. Demoré, M. Erpelding, E. Boschetti, T. May et al., Effects of an operational multidisciplinary team on hospital antibiotic use and cost in France: a cluster controlled trial, International Journal of Clinical Pharmacy, vol.29, issue.5, pp.521-529, 2011.
DOI : 10.1007/s11096-006-9059-x

S. Bauer, M. Bouldouyre, A. Oufella, P. Palmari, R. Bakir et al., Impact of a multidisciplinary staff meeting on the quality of antibiotherapy prescription for bone and joint infections in orthopedic surgery, M??decine et Maladies Infectieuses, vol.42, issue.12, pp.603-610, 2012.
DOI : 10.1016/j.medmal.2012.09.005

A. Tonna, D. Stewart, B. West, I. Gould, and D. Mccaig, Antimicrobial optimisation in secondary care: the pharmacist as part of a multidisciplinary antimicrobial programme???a literature review, International Journal of Antimicrobial Agents, vol.31, issue.6, pp.511-518, 2008.
DOI : 10.1016/j.ijantimicag.2008.01.018

V. Grenouilleau, A. Rey, and L. Faraggi, R??union de concertation pluriprofessionnelle en ??tablissement d???h??bergement pour personnes ??g??es d??pendantes??: quels impacts sur la prise en charge m??dicamenteuse des patients???, Le Pharmacien Hospitalier et Clinicien, vol.51, issue.4, pp.304-311, 2016.
DOI : 10.1016/j.phclin.2016.01.075

D. Bichard, C. Gaillard, S. Bourscheid, P. Hass, A. Batt et al., Impact d???une r??union de concertation pluridisciplinaire (RCP) sur le risque potentiel d?????v??nement ind??sirable m??dicamenteux dans une unit?? d???admission de psychog??riatrie, Le Pharmacien Hospitalier et Clinicien, vol.47, issue.3, pp.3-166, 2012.
DOI : 10.1016/j.phclin.2011.12.276

I. Schmidt, C. Claesson, B. Westerholm, L. Nilsson, and B. Svarstad, The Impact of Regular Multidisciplinary Team Interventions on Psychotropic Prescribing in Swedish Nursing Homes, Journal of the American Geriatrics Society, vol.44, issue.Suppl A&B, pp.77-82, 1998.
DOI : 10.1016/0002-9343(82)90911-1

E. Topinková, J. Baeyens, J. Michel, and P. Lang, Evidence-based strategies for the optimization of pharmacotherapy in older people. Drugs Aging, pp.477-94, 2012.

S. Al-azzam, K. Alzoubi, S. Aburuz, and Q. Alefan, Drug-related problems in a sample of outpatients with chronic diseases: a cross-sectional study from Jordan. Ther Clin Risk Manag, Feb, vol.1712, pp.233-242, 2016.

J. Pippins, T. Gandhi, C. Hamann, C. Ndumele, S. Labonville et al., Classifying and Predicting Errors of Inpatient Medication Reconciliation, Journal of General Internal Medicine, vol.227, issue.9, pp.1414-1436, 2008.
DOI : 10.1503/cmaj.045311

T. Vo, B. Charpiat, C. Catoire, M. Juste, R. Roubille et al., D??veloppement de l???echelle multidimensionelle ????Cl??o???? pour ??valuer la pertinence d???une intervention pharmaceutique, Le Pharmacien Hospitalier et Clinicien, vol.49, issue.2, 2014.
DOI : 10.1016/j.phclin.2014.04.080

J. Lacro and D. Jeste, Physical comorbidity and polypharmacy in older psychiatric patients, Biol Psychiatry, vol.36, issue.3, pp.146-52, 1994.

R. Procyshyn, A. Barr, T. Brickell, and W. Honer, Medication Errors in Psychiatry, CNS Drugs, vol.11, issue.7, pp.595-609, 2010.
DOI : 10.7326/0003-4819-117-8-684

M. Jenkins and C. Bond, The impact of clinical pharmacists on psychiatric patients, Pharmacotherapy, vol.16, issue.4, pp.708-722, 1996.

C. Alderman, A prospective analysis of clinical pharmacy interventions on an acute psychiatric inpatient unit, Journal of Clinical Pharmacy and Therapeutics, vol.22, issue.1, pp.27-31, 1997.
DOI : 10.1046/j.1365-2710.1997.95975959.x

P. Finley, M. Crismon, and A. Rush, Evaluating the Impact of Pharmacists in Mental Health: A Systematic Review, Pharmacotherapy, vol.59, issue.19, pp.1634-1678, 2003.
DOI : 10.1136/bmj.321.7252.24

K. Gardner, L. Diefenderfer, L. Nelson, C. Iuppa, E. Elliott et al., Cost-avoidance and qualitative analysis of clinical pharmacy interventions by psychiatric pharmacy residents at state psychiatric facilities, American Journal of Health-System Pharmacy, vol.73, issue.1, pp.46-53, 2016.
DOI : 10.2146/ajhp150368

S. Morcos, S. Francis, and C. Duggan, Where are the weakest links?: A descriptive study of discrepancies in prescribing between primary and secondary sectors of mental health service provision, Psychiatric Bulletin, vol.26, issue.10, pp.371-374, 2002.
DOI : 10.1192/pb.26.10.371

N. Clarke, What the eye doesn't see: drugs psychiatrists and GPs don't know their patients are on, Psychiatric Bulletin, vol.17, issue.8, pp.469-70, 1993.
DOI : 10.1192/pb.17.8.469

K. Brownlie, C. Schneider, R. Culliford, C. Fox, A. Boukouvalas et al., Medication reconciliation by a pharmacy technician in a mental health assessment unit, International Journal of Clinical Pharmacy, vol.172, issue.2, 2014.
DOI : 10.1001/archinternmed.2012.2667

P. Bedouch, N. Sylvoz, B. Charpiat, M. Juste, R. Roubille et al., Trends in pharmacists' medication order review in French hospitals from 2006 to 2009: analysis of pharmacists' interventions from the Act-IP?? website observatory, Journal of Clinical Pharmacy and Therapeutics, vol.70, issue.1, pp.32-40, 2006.
DOI : 10.1016/j.pharma.2012.02.002

A. Wheeler, K. Crump, M. Lee, L. Li, A. Patel et al., Collaborative prescribing: a qualitative exploration of a role for pharmacists in mental health. Res Social Adm Pharm, pp.179-92, 2012.

B. Bégaud, K. Martin, A. Fourrier, and F. Haramburu, Does age increase the risk of adverse drug reaction?, Br J Clin Pharmacol, vol.54, pp.548-52, 2002.

M. Gérard, La conciliation des traitements médicamenteux en géronto-psychiatrie : quelles sources d'informations utiliser ?, Thèse de doctorat en pharmacie, 2014.

C. Paumier, D. Paolo, J. Pilliez, A. Pollet, and C. , Conciliation des traitements m??dicamenteux dans un ??tablissement de sant?? mentale??: ??valuation d???une nouvelle organisation, European Psychiatry, vol.30, issue.8, 2015.
DOI : 10.1016/j.eurpsy.2015.09.308

P. Bedouch, B. Allenet, J. Labarere, E. Brudieu, C. Chen et al., Diffusion des opinions pharmaceutiques dans le cadre d???une activit?? de pharmacie clinique en unit?? de soins, Th??rapie, vol.60, issue.5, 2005.
DOI : 10.2515/therapie:2005015

M. Montana, P. Villano, and M. Rousseau, Informatisation, évaluation et sécurisation du circuit du médicament, J Pharm Clin, vol.28, issue.2, pp.97-102, 2009.

N. Gisev, J. Bell, O. Reilly, C. Rosen, A. Chen et al., An expert panel assessment of comprehensive medication reviews for clients of community mental health teams, Social Psychiatry and Psychiatric Epidemiology, vol.31, issue.11, pp.1071-1080, 2010.
DOI : 10.1002/jppr2002323227

C. Zecchini and . Impact-clinique, économique et organisationnel des interventions pharmaceutiques lors de l'analyse des prescriptions d'anticancéreux injectables, Thèse de doctorat en pharmacie, 2015.

F. Rose, L. Escoffier, O. Conort, B. Charpiat, and R. Roubille, Etude multicentrique de l'impact économique des interventions pharmaceutiques. Gest Hosp, pp.549-554, 2009.

M. Arthur, Evaluation de l'impact clinique et économique des activités de pharmacie clinique dans un service de Médecine interne gériatrie thérapeutique du CHU de Rouen, Thèse de doctorat en pharmacie, 2015.

T. Gorce, Evaluation de l'impact économique de l'analyse pharmaceutique des prescriptions médicamenteuses : application à deux services de chirurgie digestive du CHU Toulouse, Thèse de doctorat en pharmacie, 2013.

J. Bussières, Perspective canadienne et québécoise de la pratique de la pharmacie en établissement de santé 1999-2000, Pharmactuel. Janvier, vol.34, issue.1, 2001.